CorMedix, Inc. (CRMD)
7.85
+0.08
(+1.03%)
USD |
NASDAQ |
Sep 25, 16:00
7.84
-0.01
(-0.13%)
After-Hours: 07:03
CorMedix Market Cap : 609.69M for Sept. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 25, 2026 | 609.69M |
| September 24, 2026 | 603.47M |
| September 23, 2026 | 597.26M |
| September 22, 2026 | 604.25M |
| September 21, 2026 | 603.47M |
| September 18, 2026 | 599.59M |
| September 17, 2026 | 605.03M |
| September 16, 2026 | 607.36M |
| September 15, 2026 | 602.70M |
| September 14, 2026 | 612.79M |
| September 11, 2026 | 607.74M |
| September 10, 2026 | 618.23M |
| September 09, 2026 | 631.43M |
| September 08, 2026 | 635.32M |
| September 04, 2026 | 654.73M |
| September 03, 2026 | 657.84M |
| September 02, 2026 | 668.71M |
| September 01, 2026 | 650.85M |
| August 31, 2026 | 641.53M |
| August 28, 2026 | 644.64M |
| August 27, 2026 | 645.41M |
| August 26, 2026 | 651.63M |
| August 25, 2026 | 664.83M |
| August 24, 2026 | 643.08M |
| August 21, 2026 | 636.87M |
| Date | Value |
|---|---|
| August 20, 2026 | 639.20M |
| August 19, 2026 | 661.72M |
| August 18, 2026 | 634.54M |
| August 17, 2026 | 595.71M |
| August 14, 2026 | 585.61M |
| August 13, 2026 | 632.21M |
| August 12, 2026 | 551.44M |
| August 11, 2026 | 566.97M |
| August 10, 2026 | 584.83M |
| August 07, 2026 | 583.26M |
| August 06, 2026 | 588.75M |
| August 05, 2026 | 580.91M |
| August 04, 2026 | 589.53M |
| August 03, 2026 | 591.88M |
| July 31, 2026 | 590.32M |
| July 30, 2026 | 587.18M |
| July 29, 2026 | 563.66M |
| July 28, 2026 | 576.21M |
| July 27, 2026 | 595.80M |
| July 24, 2026 | 616.97M |
| July 23, 2026 | 631.08M |
| July 22, 2026 | 622.46M |
| July 21, 2026 | 642.06M |
| July 20, 2026 | 609.92M |
| July 17, 2026 | 660.09M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Filana Therapeutics, Inc. | 36.14M |
| Eloxx Pharmaceuticals, Inc. | 60.67M |
| Breakthrough Chemistry, Inc. | 0.9243M |
| BioStem Technologies, Inc. | 73.78M |
| Cardiac Biotech Solutions, Inc. | 5.360M |
Market Cap Related Metrics
| PE Ratio | 3.730 |
| PS Ratio | 1.552 |
| PEG Ratio | 0.0205 |
| Price to Book Value | 1.323 |
| Price to Free Cash Flow | 2.869 |
| Price | 7.85 |
| Earnings Yield | 26.81% |
| PEGY Ratio | 0.0205 |
| Operating PE Ratio | 3.306 |
| Normalized PE Ratio | 3.565 |